Cadence Pharmaceuticals , Nasdaq: CADX
A biopharmaceutical company developing drug candidates for use in hospitals.
Industry: Health Care
First Day Return: +4.4%
Industry: Health Care
CADX
A biopharmaceutical company developing drug candidates for use in hospitals.
| IPO Data | |
|---|---|
| IPO File Date | 07/17/2006 |
| Offer Price | $9.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 6.0 |
| Deal Size ($mm) | $54 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 10/24/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $54 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 2004 |
| Employees at IPO | n/a |
| Website www.cadencepharm.com | |
IPO News for Cadence Pharmaceuticals
Cadence Pharmaceuticals (CADX) Performance
